Trials / Terminated
TerminatedNCT06006455
Effect of the Erchonia® LunulaLaser™ for the Treatment of Toenail Onychomycosis
An Evaluation of the Effect of the Erchonia® LunulaLaser™ for the Treatment of Toenail Onychomycosis
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Erchonia Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical study is to demonstrate the efficacy of the Erchonia LunulaLaser™, for the treatment of onychomycosis of the toenail.
Detailed description
This active test treatment group only study will evaluate the effectiveness of the Erchonia LunulaLaser™ manufactured by Erchonia Corporation (the Sponsor) for the treatment of onychomycosis of the toenail.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Erchonia LunulaLaser | 405nm violet and 635nm red laser light therapy. |
Timeline
- Start date
- 2020-06-15
- Primary completion
- 2024-07-16
- Completion
- 2024-09-10
- First posted
- 2023-08-23
- Last updated
- 2025-08-01
- Results posted
- 2025-08-01
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06006455. Inclusion in this directory is not an endorsement.